Catherine Ramsey Schulte
Stock Analyst at Robert W. Baird
(4.63)
# 892
Out of 4,662 analysts
574
Total ratings
52.1%
Success rate
11%
Average return
Main Sectors:
Stocks Rated by Catherine Ramsey Schulte
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NTRA Natera | Maintained: Buy | $265 → $348 | $311.69 | +11.65% | 42 | Aug 7, 2026 | |
| TWST Twist Bioscience | Maintained: Buy | $65 → $115 | $116.10 | -0.95% | 47 | Aug 4, 2026 | |
| CSTL Castle Biosciences | Maintained: Buy | $43 → $36 | $29.03 | +24.01% | 47 | Jul 31, 2026 | |
| TEM Tempus AI | Maintained: Buy | $59 | $49.36 | +19.53% | 4 | Jul 31, 2026 | |
| TECH Bio-Techne | Maintained: Hold | $49 → $73 | $72.22 | +1.08% | 43 | Jun 26, 2026 | |
| A Agilent Technologies | Maintained: Buy | $155 → $156 | $148.44 | +5.09% | 44 | May 26, 2026 | |
| MTD Mettler-Toledo International | Maintained: Hold | $1,445 → $1,194 | $1,399.67 | -14.69% | 28 | May 11, 2026 | |
| GH Guardant Health | Maintained: Buy | $120 → $129 | $160.12 | -19.44% | 2 | May 8, 2026 | |
| CAI Caris Life Sciences | Maintained: Buy | $28 → $22 | $20.97 | +4.91% | 3 | May 8, 2026 | |
| WAT Waters | Maintained: Buy | $363 → $387 | $401.25 | -3.55% | 44 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $82 → $70 | $70.89 | -1.26% | 2 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $129 → $117 | $113.75 | +2.86% | 43 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $53 → $43 | $42.32 | +1.61% | 14 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $653 → $639 | $589.04 | +8.48% | 56 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $249 → $245 | $199.58 | +22.76% | 30 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2 → $3 | $5.74 | -47.74% | 23 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $17 → $11 | $13.33 | -17.48% | 28 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $109 → $137 | $188.29 | -27.24% | 54 | Feb 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 8 | Apr 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $102 | $94.91 | n/a | 1 | Mar 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $8 | $2.76 | n/a | 11 | Nov 2, 2018 |
Natera
Aug 7, 2026
Maintained: Buy
Price Target: $265 → $348
Current: $311.69
Upside: +11.65%
Twist Bioscience
Aug 4, 2026
Maintained: Buy
Price Target: $65 → $115
Current: $116.10
Upside: -0.95%
Castle Biosciences
Jul 31, 2026
Maintained: Buy
Price Target: $43 → $36
Current: $29.03
Upside: +24.01%
Tempus AI
Jul 31, 2026
Maintained: Buy
Price Target: $59
Current: $49.36
Upside: +19.53%
Bio-Techne
Jun 26, 2026
Maintained: Hold
Price Target: $49 → $73
Current: $72.22
Upside: +1.08%
Agilent Technologies
May 26, 2026
Maintained: Buy
Price Target: $155 → $156
Current: $148.44
Upside: +5.09%
Mettler-Toledo International
May 11, 2026
Maintained: Hold
Price Target: $1,445 → $1,194
Current: $1,399.67
Upside: -14.69%
Guardant Health
May 8, 2026
Maintained: Buy
Price Target: $120 → $129
Current: $160.12
Upside: -19.44%
Caris Life Sciences
May 8, 2026
Maintained: Buy
Price Target: $28 → $22
Current: $20.97
Upside: +4.91%
Waters
May 6, 2026
Maintained: Buy
Price Target: $363 → $387
Current: $401.25
Upside: -3.55%
May 6, 2026
Maintained: Buy
Price Target: $82 → $70
Current: $70.89
Upside: -1.26%
May 4, 2026
Maintained: Buy
Price Target: $129 → $117
Current: $113.75
Upside: +2.86%
Apr 29, 2026
Upgraded: Buy
Price Target: $53 → $43
Current: $42.32
Upside: +1.61%
Apr 24, 2026
Maintained: Buy
Price Target: $653 → $639
Current: $589.04
Upside: +8.48%
Apr 22, 2026
Maintained: Buy
Price Target: $249 → $245
Current: $199.58
Upside: +22.76%
Feb 26, 2026
Maintained: Hold
Price Target: $2 → $3
Current: $5.74
Upside: -47.74%
Feb 12, 2026
Maintained: Buy
Price Target: $17 → $11
Current: $13.33
Upside: -17.48%
Feb 6, 2026
Maintained: Hold
Price Target: $109 → $137
Current: $188.29
Upside: -27.24%
Apr 18, 2022
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Mar 4, 2019
Maintained: Buy
Price Target: $102
Current: $94.91
Upside: n/a
Nov 2, 2018
Maintained: Buy
Price Target: $9 → $8
Current: $2.76
Upside: n/a